carvedilol has been researched along with Sarcoma 180 in 1 studies
Sarcoma 180: An experimental sarcoma of mice.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The present data suggest that oxidative damage and genotoxicity play different roles in the toxicity of cisplatin on kidneys and tumors and therefore, some antioxidants might be safe as chemoprotectors." | 1.43 | Carvedilol protects the kidneys of tumor-bearing mice without impairing the biodistribution or the genotoxicity of cisplatin. ( Antunes, LM; Baffa, O; Barbosa, F; Carvalho Rodrigues, MA; da Silva Faria, MC; dos Santos, AC; dos Santos, NA; Gobe, GC; Kinoshita, A; Rodrigues, JL, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carvalho Rodrigues, MA | 1 |
| dos Santos, NA | 1 |
| da Silva Faria, MC | 1 |
| Rodrigues, JL | 1 |
| Kinoshita, A | 1 |
| Baffa, O | 1 |
| Antunes, LM | 1 |
| Barbosa, F | 1 |
| Gobe, GC | 1 |
| dos Santos, AC | 1 |
1 other study available for carvedilol and Sarcoma 180
| Article | Year |
|---|---|
Carvedilol protects the kidneys of tumor-bearing mice without impairing the biodistribution or the genotoxicity of cisplatin.
Topics: Animals; Antineoplastic Agents; Antioxidants; Carbazoles; Carvedilol; Cisplatin; Kidney; Male; Propa | 2016 |